Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Creating a Universal Standard for Lab Test Names
A multidisciplinary collaborative works to eliminate confusion, errors, and waste from the laboratory test ordering process.
CHA Response to Drug Shortages White Paper
CHA submitted comments on a drug shortages white paper to highlight pediatric health care needs.
5 Reasons to Start a Specialty Pharmacy
For many children’s hospitals and health systems, the benefits of an internal specialty pharmacy outweigh the costs.